Approved Hospital Formulary
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:

romiPLOStim

romiPLOStim
Brand names: Nplate
Form Strength
POWDER FOR INJECTION, SUBCUTANEOUS 125 mcg, 250 mcg, 500 mcg

VIEW MORE Hematopoietic Agents
CLASS
201600

Additional Information:

This medication is Inpatient Formulary with Restrictions.  Criteria for use:

    • Ordered by a hematologist/oncologist
    • Time to treatment escalation for treating ITP:
      • At least 3 days of steroids prior to escalation (unless previously documented failure)
      • At least 2 doses of IVIG prior to escalation (unless previously documented failure)

UNLESS:

    • Patient is experiencing bleeding or is considered at critical/severe risk of bleeding (platelets < 20,000/mm3)

 

    • RomiPLOStim additional criteria: Unable to take PO medication (if able to take PO, preferentially utilize eltrombopag)
  •  
  •  
    • NOTE: Optimize vial size when utilizing romiPLOStim.  Ie: a 125 mcg vial plus a 250 mcg vial is more cost effective than a 500 mcg vial.

 


Last updated: Jul. 1, 2025







This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.